http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3414509-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 |
| filingDate | 1984-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3166ac2742ed8d27971a1a42e170bacb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e453021d11b44be524a00764ac639ef2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e8d80282b67bad4a4a68d337f3d45b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b83f9e80df8e9ba52e50d9fd0b2045a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27eeb9104885f3fe666dbe3e49ecfe5c |
| publicationDate | 1985-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3414509-A1 |
| titleOfInvention | NEW 9-HALOGEN PROSTAGLANDINE |
| abstract | 9-halogen-prostane having the formula (I) wherein Hal represents a chlorine or fluorine atom in position alpha or beta ; R1 represents the rest CH2OH or the formula (A) with R2 representing a hydrogen atom, an alkyl, cycloalkyl, aryl or heterocyclic rest or R1 represents the rest of formula (B) with R3 representing an acid rest or the rest R2; A is a group -CH2-CH2-, -CH=CH- trans or -C=C-; W is free or functionally transformed hydroxy methylene group or a free or functionally transformed group having the formula (C), the group OH susceptible of being in position alpha or beta ; D and E represent together a direct bound or D represents a straight branched or cyclic chain alkylene group with 1 to 10 atoms of carbon, substituted optionally by fluorine atoms, and E represents oxygen or sulfur, a direction bound, a bound -C=C- or a group -CR6=CR7, R6 and R7 being different and representing hydrogen, chlorine or alkyl with 1 to 4 atoms of carbon; R4 is a free or functionally modified hydroxy group; R5 is a hydrogen atom, an alkyl, a halogen-substituted alkyl, a cycloalkyl, an optionally substituted aryl or a heterocyclic group; as well as, if R2 represents a hydrogen atom, the salts thereof with physiologically acceptable bases, the preparation process thereof and the pharmaceutical utilization thereof. |
| priorityDate | 1984-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.